Burcon NutraScience Corporation (BU : TSX)
Common Stock
$2.20
CAD
+0.00 (%)
Last updated: 2026-06-22
BU
Burcon NutraScience Corporation
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+2.80%
1 Month
+9.45%
YTD
+27.17%
Key Statistics
Market Cap
$27.92M
52W High
$5.00
52W Low
$1.51
P/E Ratio
-
50 Day MA
$2.11
200 Day MA
$2.06
Beta
2.90
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/22/2026 | $2.14 | $2.20 | $2.14 | $2.20 | $2.20 | 2,400 |
| 6/19/2026 | $2.20 | $2.20 | $2.20 | $2.20 | $2.20 | 400 |
| 6/18/2026 | $2.20 | $2.20 | $2.20 | $2.20 | $2.20 | 1,902 |
| 6/17/2026 | $2.24 | $2.24 | $2.14 | $2.14 | $2.14 | 200 |
| 6/16/2026 | $2.13 | $2.24 | $2.13 | $2.24 | $2.24 | 5,518 |
| 6/15/2026 | $2.25 | $2.25 | $2.14 | $2.14 | $2.14 | 3,309 |
| 6/12/2026 | $2.25 | $2.32 | $2.25 | $2.30 | $2.30 | 10,618 |
| 6/11/2026 | $2.11 | $2.30 | $2.11 | $2.30 | $2.30 | 15,051 |
| 6/10/2026 | $2.10 | $2.10 | $2.07 | $2.07 | $2.07 | 7,161 |
| 6/9/2026 | $2.10 | $2.10 | $2.06 | $2.06 | $2.06 | 12,612 |
Analyst Price Targets
Based on analyst covering BU
Wall Street analysts forecast BU stock price to fall 15.9% over the next 12 months.
Consensus
No RatingAvg. Target
C$1.85
-15.9% Upside
Current Price
C$2.20
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BU's historical volatility
30-Day Vol
56.7%
Annualized
90-Day Vol
74.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.63
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.33 | C$1.92 โ C$2.84 |
| 60 trading days | C$2.48 | C$1.88 โ C$3.27 |
| 90 trading days | C$2.63 | C$1.87 โ C$3.69 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Burcon NutraScience Corporation
Burcon NutraScience Corporation, together with its subsidiaries, provides plant-based proteins for the food and beverage industry in Canada. The company offers peas, which includes Peazazz, a pea protein for use in dairy alternatives; and canola protein, which comprises meat alternatives, egg alternatives, non-dairy frozen desserts, ready-to-mix beverages, whipped toppings and nutrition bars, and other concentrated protein supplements. It also provides soy that includes soy protein, a protein replacement for dairy proteins in food or in products, such as protein shakes, power bars, soups and sauces, meat alternatives, and breads and baked goods; and CLARISOY for sports nutrition beverages, citrus-based drinks, fruit-flavoured beverages, lemonades, powdered beverage mixes, and in various non-beverage plant-based applications. In addition, the company offers Solatein, a sunflower protein isolate; FavaPro fava protein and other plant proteins; hemp protein isolate; flax protein; and protein blends. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was incorporated in 1998 and is headquartered in Vancouver, Canada.
Financials
- Revenue (TTM)
- $1.48M
- EBITDA
- $-8.93M
- Profit Margin
- 0.00%
- ROE (TTM)
- -1245.82%
- EPS (Diluted)
- -1.07
- Book Value
- -0.20
Classification
- Sector
- Consumer Staples
- Industry
- Food Products
- Group
- Food, Beverage & Tobacco
๐ Recent Splits
1-for-20
Jun 11, 2025
1209-for-1000
Nov 27, 2024
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About BU
Articles Featuring BU.TO
Latest articles and analysis covering BU.TO
Why Burcon NutraScience Corporation stock is rising today
Burcon NutraScience Corporation's stock rose by 3.64% in the latest trading session, driven by impressive production growth and strategic financial actions. With a focus on plant-based protein, the company is positioning itself for future success.
Why Burcon NutraScience Corporation stock is sliding today
Burcon NutraScience Corporation's stock has taken a hit, down 4.46% in the last trading session. Investors are left to ponder the implications of this decline amidst a backdrop of limited news and market volatility.
Why Burcon NutraScience Corporation stock is sliding today
Burcon NutraScience Corporation's stock slid 4.46% in the last trading session, closing at CA$2.14. With a small market cap of CA$27 million, the company's recent performance raises questions about its stability and growth prospects.
Why Burcon NutraScience Corporation stock is rising today
Burcon NutraScience Corporation's stock rose significantly in the last session, driven by positive developments in production and customer expansion.
Why Burcon NutraScience Corporation stock is plummeting today
Burcon NutraScience Corporation's stock plummeted by nearly 7% today, raising concerns about its future in the competitive plant-based ingredient market.
Why Burcon NutraScience Corporation stock is skyrocketing today
Burcon NutraScience Corporation's stock jumped by 11.11% to CA$2.30, driven by optimism in the plant-based protein sector. While the surge reflects positive market sentiment, investors should stay alert for any potential volatility.
Why Burcon NutraScience Corporation stock is gaining today
Burcon NutraScience Corporation's stock surged by 1.94% today, closing at CA$2.10, driven by investor confidence in its production capabilities and expanding customer base.
Why Burcon NutraScience Corporation stock is plummeting today
Burcon NutraScience Corporation (BU.TO) has seen a significant decline in its stock price, closing down 6.06% despite recent positive developments, raising concerns about future investor confidence.
Why Burcon NutraScience Corporation stock is rising today
Burcon NutraScience Corporation's stock rose by 4.76% in the last trading session, driven by a significant revenue increase and plans for capacity expansion. With a market cap of CA$23.99 million, the company is gaining traction in the plant-based protein sector.
